AO-128
AO-128/OCT-910
Approved small_molecule completed
Quick answer
AO-128 for Impaired Glucose Tolerance (IGT) is a Approved program (small_molecule) at Takeda Pharmaceuticals International AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Takeda Pharmaceuticals International AG
- Indication
- Impaired Glucose Tolerance (IGT)
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed